Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
557.50    0.50 (0.09%)
Bid:
557.00
Ask:
557.50
Spread: 0.50 (0.09%)
Market Cap: £2.47b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

4 Jan 2017 15:11

Tate & Lyle PLC

Notification of transactions by Persons Discharging Managerial Responsibilities

Tate & Lyle PLC (the “Company”) has been informed that following the purchase of ordinary shares of 25 pence each in the capital of the Company (“Shares”) on 3 January 2017 under the terms of the Tate & Lyle PLC Dividend Reinvestment Plan (“DRIP”), two Persons Discharging Managerial Responsibilities (“PDMR”) and their persons closely associated have acquired interests in additional Shares at a purchase price of 696.03 pence per Share. The details of the purchases are summarised below:

PDMR (and person closely associated) Total No. of Shares acquired Total interest in Shares following the purchase
Sir Peter Gershon (Chairman) 1,789 155,146
Javed Ahmed (Chief Executive) 12,013 3,098,850

The notifications below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Jaime Tham

Deputy Company Secretary

4 January 2017

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Details of PDMR / person closely associated with them (“PCA”)
a) Name Sir Peter Gershon
2. Reason for the notification
a) Position / status PDMR – Chairman
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Acquisition of shares under the Tate & Lyle PLC Dividend Reinvestment Plan. 1,005 shares were acquired jointly by Sir Peter and Lady Eileen Gershon and an additional 749 shares were acquired by Sir Peter Gershon as sole holder.
c) Price(s) and volume(s)

Price(s)

696.03 pence

Volume(s)

1,754

d) Aggregated information

Aggregated volume Price

1,754

GB12,208.37

e) Date of the transaction 2017-01-03
f) Place of the transaction London Stock ExchangeXLON

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of PDMR / person closely associated with them (“PCA”)
a) Name Lady Eileen Gershon
2. Reason for the notification
a) Position / status PCA of Sir Peter Gershon (Chairman)
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Acquisition of shares under the Tate & Lyle PLC Dividend Reinvestment Plan. 1,005 shares were acquired jointly by Sir Peter and Lady Eileen Gershon and an additional 35 shares were acquired by Lady Eileen Gershon as sole holder.
c) Price(s) and volume(s)

Price(s)

696.03 pence

Volume(s)

1,040

d) Aggregated information

Aggregated volume Price

1,040

GBP7,238.71

e) Date of the transaction 2017-01-03
f) Place of the transaction London Stock ExchangeXLON

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of PDMR / person closely associated with them (“PCA”)
a) Name Javed Ahmed
2. Reason for the notification
a) Position / status PDMR – Chief Executive
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Acquisition of shares under the Tate & Lyle PLC Dividend Reinvestment Plan held jointly by Mr and Mrs Ahmed. The volume of shares acquired in (c) below is the total number of shares acquired by Mr and Mrs Ahmed in respect of their joint holding.
c) Price(s) and volume(s)

Price(s)

696.03 pence

Volume(s)

12,013

d) Aggregated information

Aggregated volume Price

12,013

GBP83,614.08

e) Date of the transaction 2017-01-03
f) Place of the transaction London Stock ExchangeXLON

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of PDMR / person closely associated with them (“PCA”)
a) Name Talat Ahmed
2. Reason for the notification
a) Position / status PCA of Javed Ahmed (Chief Executive)
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Acquisition of shares under the Tate & Lyle PLC Dividend Reinvestment Plan held jointly by Mr and Mrs Ahmed. The volume of shares acquired in (c) below is the total number of shares acquired by Mr and Mrs Ahmed in respect of their joint holding.
c) Price(s) and volume(s)

Price(s)

696.03 pence

Volume(s)

12,013

d) Aggregated information

Aggregated volume Price

12,013

GBP83,614.08

e) Date of the transaction 2017-01-03
f) Place of the transaction London Stock ExchangeXLON

View source version on businesswire.com: http://www.businesswire.com/news/home/20170104005969/en/

Copyright Business Wire 2017

Date   Source Headline
11th Aug 20251:00 pmRNSDirector/PDMR Shareholding
5th Aug 20257:00 amRNSDirector/PDMR Shareholding
1st Aug 202511:00 amRNSTotal Voting Rights
24th Jul 20252:30 pmRNSResult of Annual General Meeting 2025
15th Jul 20251:00 pmRNSDirector/PDMR Shareholding
1st Jul 20253:30 pmRNSBlock listing Interim Review
1st Jul 20257:00 amRNSTate & Lyle Capital Markets Event
13th Jun 20253:00 pmRNSHolding(s) in Company
11th Jun 20254:30 pmRNSDirector/PDMR Shareholding
5th Jun 20252:30 pmRNSAnnual Financial Report and Notice of Meeting 2025
5th Jun 20252:00 pmRNSDirector/PDMR Shareholding
2nd Jun 202512:30 pmRNSTotal Voting Rights
28th May 202512:00 pmRNSDirector/PDMR Shareholding
27th May 202512:00 pmRNSDirector/PDMR Shareholding
23rd May 202510:00 amRNSDirector/PDMR Shareholding
22nd May 20257:00 amRNSFinal Results
14th May 20259:00 amRNSHolding(s) in Company
1st May 20253:00 pmRNSHolding(s) in Company
29th Apr 20253:30 pmRNSHolding(s) in Company
28th Apr 20255:15 pmRNSHolding(s) in Company
24th Apr 202512:00 pmRNSHolding(s) in Company
15th Apr 20257:00 amRNSIntegration update and pre-close statement
27th Mar 20257:00 amRNSDirectorate Change
14th Mar 202510:05 amRNSDirectorate declaration
11th Mar 20253:00 pmRNSHolding(s) in Company
5th Mar 202511:30 amRNSDirector/PDMR Shareholding
28th Feb 20254:30 pmRNSHolding(s) in Company
28th Feb 202510:15 amRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSAdditional Listing
20th Feb 20251:42 pmRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSTrading Statement
4th Feb 20257:05 amRNSDirector Declaration
3rd Feb 20253:30 pmRNSTotal Voting Rights
23rd Jan 20255:30 pmRNSIssue of Debt
9th Jan 20255:54 pmRNSCompletion of Share Buyback Programme
9th Jan 20255:45 pmRNSTransaction in Own Shares
8th Jan 20255:17 pmRNSTransaction in Own Shares
8th Jan 20252:02 pmRNSDirector/PDMR Shareholding
7th Jan 20255:31 pmRNSTransaction in Own Shares
6th Jan 20256:10 pmRNSTransaction in Own Shares
6th Jan 20252:00 pmRNSDirectorate Change
3rd Jan 20255:28 pmRNSTransaction in Own Shares
2nd Jan 20255:20 pmRNSTransaction in Own Shares
2nd Jan 20252:10 pmRNSBlock listing Interim Review
2nd Jan 20252:00 pmRNSTotal Voting Rights
30th Dec 20245:36 pmRNSTransaction in Own Shares
27th Dec 20245:15 pmRNSTransaction in Own Shares
23rd Dec 20245:26 pmRNSTransaction in Own Shares
20th Dec 20245:31 pmRNSTransaction in Own Shares
19th Dec 20245:24 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.